Bortirel 3.5 mg Injection
$41.68
$37.09
Bortirel 3.5 mg Injection is an innovative anticancer treatment specifically designed to combat multiple myeloma, a malignancy that originates in the bone marrow, as well as mantle cell lymphoma, a rapidly advancing cancer affecting the immune system. This powerful injection functions by inhibiting certain proteins found within cancer cells, leading to their eventual destruction and providing hope for patients battling these aggressive forms of cancer. It is crucial for patients to discuss potential side effects and contraindications with their healthcare provider prior to starting this treatment, as Bortirel may not be suitable for everyone. With its targeted approach, Bortirel 3.5 mg aims to improve patient outcomes by effectively managing symptoms and slowing disease progression. As part of a comprehensive cancer treatment plan, it may be combined with other therapies to enhance efficacy. Patients are encouraged to adhere to their prescribed regimen and report any unusual symptoms to their physician promptly. Overall, Bortirel 3.5 mg Injection represents a significant advancement in oncology, offering new avenues of hope for individuals facing challenging cancer diagnoses.
Quantity
Active Pharmaceutical Ingredient
Uses
• Bortirel 3 5 mg injection is primarily used in the treatment of multiple myeloma, a cancer affecting plasma cells in the bone marrow. This medication works by targeting the abnormal plasma cells that disrupt normal blood cell production. Patients receiving Bortirel may experience a reduction in symptoms such as bone pain and fatigue. Its effectiveness helps improve the overall quality of life for those battling this condition.
• Another significant application of Bortirel 3 5 mg injection is in the treatment of mantle cell lymphoma, a rare and aggressive form of non-Hodgkin lymphoma. This condition arises from B cells, and Bortirel aids in managing the growth of these cancerous cells. By using Bortirel, healthcare providers aim to alleviate symptoms such as swollen lymph nodes and persistent fatigue. The injection is a vital part of the treatment plan for patients diagnosed with this challenging lymphoma.
• Bortirel 3 5 mg injection is beneficial for patients who have relapsed or refractory multiple myeloma, where previous treatments have not yielded the desired results. This medication helps to re-sensitize the cancer cells to treatment, providing a new avenue for managing the disease. By incorporating Bortirel into their therapeutic regimen, patients may experience improved responses and symptom relief. This approach represents hope for those facing difficult treatment scenarios.
• In addition to its primary uses, Bortirel 3 5 mg injection may be utilized in combination with other therapies to enhance treatment efficacy for various hematological malignancies. This synergistic effect can lead to better outcomes for patients with conditions like multiple myeloma and mantle cell lymphoma. Bortirel is a crucial component of multi-drug regimens aimed at maximizing patient response. Its role underscores the importance of personalized treatment strategies in oncology.
Benefits
Bortirel 3.5 mg Injection contains the active substance bortezomib, also called ‘proteome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, it can kill cancer cells. Bortirel 3.5 mg is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer affecting the lymph nodes) in people 18 years or older. It may be used alone or together with other medicines.
Side Effects
Like all medications, Bortirel 3.5mg Vial can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Burning feeling of skin
• Stomach Pain
• Insomnia
• Dehydration
• Pneumonia
• High fever
Common Side Effects
• High Blood Pressure
• Tiredness
• Cough
• Chest Tightness
• Feet Swelling
How To Use
Bortirel 3.5 mg is administered intravenously or subcutaneously at a hospital or clinic setting by a doctor or nurse. Your doctor will decide the right time to take the injection, so always follow your doctor's advice. The dose and how often you take it depend on what you are taking it for. You might be prescribed certain other medicine as a part of your treatment. You should take this medicine for as long as it is prescribed for you.
Safety Advice
• Alcohol: Consumption of alcohol is not recommended while using Bortirel 3.5mg Vial. Alcohol may increase or decrease the effectiveness of the medicine and also increase the risk of side effects. It is the best advice for you: before consuming alcohol, you can talk with a doctor or pharmacist, and they will tell you if consumption of alcohol is safe or not.
• Kidney: Bortirel 3.5mg Vial should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Bortezomib 3.5 mg Injection and report any unusual symptoms or changes in kidney function to their doctor. Your doctor may need to adjust the dose in such kidney disease patients.
• Breastfeeding: It is unknown whether Bortirel Cancer Injection is excreted in human milk. If you are breastfeeding and taking this medicine. It is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Bortirel 3.5 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Bortezomib 3.5 mg Injection and report any unusual symptoms or changes in liver function to their doctor. Your doctor may need to adjust the dose in such liver disease patients.
• Pregnancy: Animal reproduction studies have not been conducted with Bortirel Cancer Injection. Bortirel 3.5 mg Injection is generally considered unsafe during pregnancy. If you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Bortirel 3.5 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Bortirel 3.5 mg Injection will not affect your ability to drive or operate machinery. In case you experience any side effects while taking Bortezomib 3.5 mg Injection, such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.